Hampel, P., Römermann, K., MacAulay, N., & Löscher, W. (2018). Azosemide is more potent than bumetanide and various other loop diuretics to inhibit the sodium-potassium-chloride-cotransporter human variants hNKCC1A and hNKCC1B. Sci Rep.
Citación estilo ChicagoHampel, Philip, Kerstin Römermann, Nanna MacAulay, and Wolfgang Löscher. "Azosemide Is More Potent Than Bumetanide and Various Other Loop Diuretics to Inhibit the Sodium-potassium-chloride-cotransporter Human Variants HNKCC1A and HNKCC1B." Sci Rep 2018.
Cita MLAHampel, Philip, Kerstin Römermann, Nanna MacAulay, and Wolfgang Löscher. "Azosemide Is More Potent Than Bumetanide and Various Other Loop Diuretics to Inhibit the Sodium-potassium-chloride-cotransporter Human Variants HNKCC1A and HNKCC1B." Sci Rep 2018.